Botox 200 unit vials
Ended Awarded
- Contract number
- SPE2DB25FZX94
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,881
Award facts
- Contract value 100% obligated
- $3,881.10 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $3,881.10 to DMS Pharmaceutical Group Inc. for the supply of BOTOX 200 unit vials. The award, issued on September 11, 2025, with an ultimate completion date of October 2, 2025, carries no set-aside designation. DMS Pharmaceutical Group, a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will fulfill this order from its location in Park Ridge, IL. This delivery order is issued under DMS Pharmaceutical Group's larger single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering branded and generic prescription drugs, biologics, and medical consumables to military healthcare facilities across the nation. The company's extensive contract portfolio with the DLA demonstrates its capability to meet federal procurement requirements for specialty pharmaceutical products including injectable medications and biologics. This BOTOX delivery order exemplifies the company's role in supporting Department of Defense healthcare operations by providing essential pharmaceutical products at firm fixed prices through the DLA's comprehensive pharmaceutical supply framework.
Quick answers
Who was awarded contract SPE2DB25FZX94?
SPE2DB25FZX94 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FZX94 worth?
The government has obligated $3,881 on SPE2DB25FZX94.
Is contract SPE2DB25FZX94 an order under another contract?
Yes. SPE2DB25FZX94 is a delivery order under SPE2DB20D9135, an indefinite delivery contract.
Was contract SPE2DB25FZX94 competed?
The extent of competition for SPE2DB25FZX94 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award